Inventor

Jun Liang

Inventor
Palo Alto, CA, US

Overview

39→
Patents
2009–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes2%
A61NElectrotherapy1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07KPeptides1%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients1%
C09DCoating compositions, e.g. paints, varnishes or lacquers1%
C23CCoating metallic material1%
PatentTitleYear
10,654,867Heteroaryl estrogen receptor modulators and uses thereof202010,407,424Naphthyridines as inhibitors of HPK1201910,399,939Tetrahydronaphthalene estrogen receptor modulators and uses thereof201910,301,480Chromium-free insulation coating composition, method for making same, and grain oriented silicon steel sheet201910,280,149Therapeutic compounds and uses thereof201910,202,354Therapeutic compounds and uses thereof201910,053,451Heterocyclic estrogen receptor modulators and uses thereof201810,035,801Pyrazolo compounds and uses thereof201810,022,354Pyrrolidine amide compounds as histone demethylase inhibitors20189,980,947Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof20189,969,732Tetrahydroisoquinoline estrogen receptor modulators and uses thereof20189,845,291Estrogen receptor modulators and uses thereof20179,505,767'Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors'20169,434,732'Triazolopyridine JAK inhibitor compounds and methods'20169,409,886'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20169,359,340'Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20169,328,091'5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors'20169,309,240'Pyrazolopyridine compounds, compositions and methods of use'20168,895,566'5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors'20148,853,199'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,853,216'Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor'20148,846,681'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,846,683'Pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20148,835,434'Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors'20148,828,215'Process for producing a coating on the surface of a substrate based on lightweight metals by plasma-electrolytic oxidation'20148,697,708'Azabenzothiazole compounds, compositions and methods of use'20148,618,097'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,609,687'Triazolopyridine JAK inhibitor compounds and methods'20138,486,950'Janus kinase inhibitor compounds and methods'20138,377,937'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,329,709'5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors'20128,063,050'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20118,008,317'Inhibitors of akt activtiy'20118,003,651'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20117,910,561'Inhibitors of Akt activity'20117,749,994'Pentacyclic kinase inhibitors'20107,741,453'Long lasting fusion peptide inhibitors for HIV infection'20107,589,068'Inhibitors of Akt activity'20097,544,677'Inhibitors of Akt activity'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2019Based in Palo Alto, CA, US· patent location history
2010–2020Patents assigned to GENENTECH INC (29)· patent assignee history
2011–2016Patents assigned to ARRAY BIOPHARMA INC (14)· patent assignee history
2011–2014Patents assigned to LIANG JUN (12)· patent assignee history
2011–2014Patents assigned to KALLAN NICHOLAS C (8)· patent assignee history
2011–2014Patents assigned to MITCHELL IAN S (8)· patent assignee history
2012–2019Based in South San Francisco, CA, US· patent location history
2014Based in Lanzhou, CN· patent location history
2017–2020Based in Los Altos Hills, CA, US· patent location history
2019Based in Wuhan, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC292010–2020
ARRAY BIOPHARMA INC142011–2016
LIANG JUNself122011–2014
KALLAN NICHOLAS C82011–2014
MITCHELL IAN S82011–2014
Locations
LocationPatentsSpan
Palo Alto, California, US192009–2019
South San Francisco, California, US132012–2019
Los Altos Hills, California, US42017–2020
Wuhan, CN12019
Lanzhou, CN12014